00d:00h:00m:00s
AI Growth Summit: 9 Tactics to Add $10m FastJune 30
121/150seats takenSave Your Seat
Latka logo

Valuation

$63.3M

2024 Revenue

$21.1M(Est.)

Funding

$0

Team

115

Founded

2010

Sanguine Biosciences Revenue & Valuation (2024)

Company empowering patients with their health care data and facilitating patient participation in biomedical research, accelerating the personalized-medicine research options

Last updated

Sanguine Biosciences Revenue

In 2024, Sanguine Biosciences's revenue reached $21.1M. Since its launch in 2010, Sanguine Biosciences has shown consistent revenue growth.

Sanguine Biosciences Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$5M$10M$15M$20M$25M20102012201420162018202020222024$0$21.1MSource: GetLatka.com
YearMilestoneSource
2024Sanguine Biosciences Hit $21.1m revenue in June 2024Estimated
2010Launched with $0 revenue

Sanguine Biosciences Valuation, Funding Rounds

Sanguine Biosciences's most recent disclosed valuation is $63.3M.

Sanguine Biosciences Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$0.2$0.4$0.4$0.6$0.6$0.8$0.8$1$12010Source: GetLatka.com
YearRoundAmountValuation% SoldSource

Founder / CEO

Brian Neman

CEO

Brian Neman is listed as CEO at Sanguine Biosciences.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Sanguine Biosciences yet.

Sanguine Biosciences Employees & Team Size

Sanguine Biosciences employs approximately 115 people as of 2026.

Sanguine Biosciences Team GrowthReported headcount over time02550751001252010201220142016201820202022202400115115Source: GetLatka.com
YearMilestoneSource
2024Reached 115 employees (December 2024)
2024Reached 119 employees (July 2024)

Frequently Asked Questions about Sanguine Biosciences

What is Sanguine Biosciences's revenue?

Sanguine Biosciences generates an estimated $21.1M in annual revenue.

Who founded Sanguine Biosciences?

Sanguine Biosciences was founded by Brian Neman.

Who is the CEO of Sanguine Biosciences?

The CEO of Sanguine Biosciences is Brian Neman.

How much funding does Sanguine Biosciences have?

Sanguine Biosciences raised $0.

How many employees does Sanguine Biosciences have?

Sanguine Biosciences has 115 employees.

Where is Sanguine Biosciences headquarters?

Sanguine Biosciences is headquartered in Woburn, Massachusetts, United States.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile

People Also Viewed

Tamigo logo

Tamigo

Developer of a cloud-based workforce management platform designed to focus on the optimization of operations and staff management. The company's platform combines scheduling, absence management, performance, employee communication, HR, finance and forecasting, enabling clients to automate manual time-consuming processes and show relevant data to relevant people.

Doctify logo

Doctify

Doctify provides a solution for the millions of patients who want to search, compare and book health services over the internet.

Candi Solar logo

Candi Solar

Candi Solar partners with businesses to provide simple, end-to-end solar & battery solutions. Our flexible approach, coupled with our financial expertise, enables us to tailor an offering to your exact needs. Our shared value model guarantees we are invested for the long run, owning the risk and ensuring you reap the full rewards.

SysTools logo

SysTools

SysTools is the leading name in the IT industry. Since its establishment, the company has assisted users across the globe in the field of Cloud Migration, Data Recovery, Digital Forensics, and Cyber Security. We are in the business of providing high-tech solutions and indigenous tools that offer users the solution they have been looking for. Our team has come up with 250+ robust and cost-effective IT solutions. In fact, we are the only Make-in-India company whose email forensics tool – MailXaminer is popular among well-known law enforcement agencies and recognized industries around the world. Walmart, SAP, APTEGRA, Columbia University, Delhi Police, Income Tax Department, etc are to name a few. Being an ISO 9001:2015 and 27001:2013 certified company, we are committed to delivering quality service to our clients. Over the years, we have built a strong team who are actively available 24X7 to give you the best experience. With the latest and advanced tools for forensic analysis, we have made our mark in the field of Digital Forensics. Slowly, we are making the digital space secure for users with our Managed Cybersecurity Services. Specialties Data Backup, Cloud Migration, Cloud Backup, Data Recovery, Digital Forensics, Email Forensics, Cybersecurity - SOC - NOC - VAPT services, and more.

Restrata logo

Restrata

Restrata provides an integrated platform for operational resilience and holistic people safety, resilienceOS, that unifies data from people, sites, and independent risk data providers to deliver real-time intelligence across global operations in one picture. Trusted by enterprises in 50+ countries, resilienceOS helps organisations anticipate, respond to, and recover from disruptions fast. Whether managing travel risk, lone workers, or full-scale crisis events, Restrata empowers companies to protect all their people, assets, operations, and reputation - all the time.

MIND CTI logo

MIND CTI

MIND is a leading provider of convergent real-time end-to-end billing and customer care product based solutions as well as call accounting solutions for organizations and large multinational corporates. MIND delivers its applications in any business model (license, managed service or complete outsourced billing service) for Mobile, Wireline, VoIP and Quad-play carriers worldwide. MIND is a global company, with over ten years of experience in providing solutions to carriers and enterprises.

Sanguine Biosciences Revenue 2024: $21.1M Est. ARR